Assessment and comparison of CISNE model versus MASCC model in clinically stable febrile neutropenia patients

被引：0

作者：

Koppaka, D. ^{[1
]}

Kuntegowdanahalli, L. C. ^{[1
]}

Lokanath, D. ^{[1
]}

Babu, K. Govind ^{[1
]}

Jacob, L. A. ^{[1
]}

Babu, M. C. Suresh ^{[1
]}

Lokesh, K. N. ^{[1
]}

Rudresha, A. H. ^{[1
]}

Rajeev, L. K. ^{[1
]}

Smitha, S. C. ^{[1
]}

Anand, A. ^{[1
]}

Asati, V. ^{[1
]}

Chethan, R. ^{[1
]}

Patidar, R. ^{[1
]}

Chaudhuri, T. ^{[1
]}

Kasturi, A. ^{[2
]}

机构：

[1] Kidwai Canc Inst, Med Oncol, Bengaluru, India

[2] Cloudnine Hosp, Dept Anaesthesia, Bengaluru, India

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

421O

引用

页码：129 / 129

页数：1

共 50 条

[11] Performance of the clinical index of stable febrile neutropenia (CISNE) in different types of infections and tumors
Carmona-Bayonas, A.
Jimenez-Fonseca, P.
Virizuela, J.
Antonio, M.
Font, C.
Biosca, M.
Ramchandani, A.
Martinez-Garcia, J.
Hernando, J.
Espinosa, J.
de Castro, E. M.
Ghanem, I.
Beato, C.
Blasco, A.
Garrido, M.
Mondejar, R.
Arcusa, M. A.
Aragon, I.
Manzano, A.
Sevillano, E.
Castanon, E.
Ayala, F.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (03): : 386 - 395
[12] Prediction of major complications in patients with solid tumors and apparently stable febrile neutropenia: Validation of the CISNE risk score
Espinosa, Javier
Font, Carme
Jimenez-Fonseca, Paula
Biosca, Merce
Ramchandani, Avinash
Antonio Rebollo, Maite
Martinez de Castro, Eva
Hernando, Jorge
Ghanem, Ismael
Martinez, Jeronimo
Beato, Carmen
Blasco, Ana
Casao, Filipe
Bonilla, Yaiza
Mondejar, Rebeca
Arcusa Lanza, Maria Angeles
Gallardo Martin, Elena
Virizuela Echaburu, Juan
Ayala, Francisco
Carmona Bayonas, Alberto
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[13] Applications for the MASCC Risk Index for Febrile Neutropenia in Patients with Hematologic Malignancy
O'Neal, Richard
Roberts, Kandice
Chen, Quan
Huang, Bin
Saeed, Hayder
Ramlal, Reshma
Monohan, Gregory
Hildebrandt, Gerhard C.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
[14] Common misconceptions in the prognostic evaluation of clinically stable patients with febrile neutropenia and solid tumors
A. Carmona-Bayonas
P. Jiménez-Fonseca
Clinical and Translational Oncology, 2019, 21 : 1112 - 1114
[15] Common misconceptions in the prognostic evaluation of clinically stable patients with febrile neutropenia and solid tumors
Carmona-Bayonas, A.
Jimenez-Fonseca, P.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (08): : 1112 - 1114
[16] Validation of MASCC Score for Risk Stratification in Patients of Hematological Disorders with Febrile Neutropenia
M. Taj
M. Nadeem
S. Maqsood
T. Shah
T. Farzana
T. S. Shamsi
Indian Journal of Hematology and Blood Transfusion, 2017, 33 : 355 - 360
[17] Validation of MASCC Score for Risk Stratification in Patients of Hematological Disorders with Febrile Neutropenia
Taj, M.
Nadeem, M.
Maqsood, S.
Shah, T.
Farzana, T.
Shamsi, T. S.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2017, 33 (03) : 355 - 360
[18] EVALUATION OF THE COMPLICATION RATE AND COST OF TREATMENT ACCORDING TO THE MASCC INDEX IN PATIENTS WITH FEBRILE NEUTROPENIA
Borget, I
Bonnet, P.
Gachot, B.
Di Palma, M.
Antoun, S.
Merad, M.
VALUE IN HEALTH, 2009, 12 (07) : A267 - A267
[19] Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department
Coyne, Christopher J.
Le, Vivian
Brennan, Jesse J.
Castillo, Edward M.
Shatsky, Rebecca A.
Ferran, Karen
Brodine, Stephanie
Vilke, Gary M.
ANNALS OF EMERGENCY MEDICINE, 2017, 69 (06) : 755 - 764
[20] Retrospective study on the correlation between MASCC score and the evolution of febrile neutropenia for patients with solid cancer
Rivest, Charles-Eric
Ben Abderrazik, Fatim Ezzahra
Cote-Marcoux, Marc-Antoine
Malick, Mandy
Hanel, Robert
Pavic, Michel
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)

← 1 2 3 4 5 →